Malaysia vs Ukraine: The number of people with susceptibility test result for rifampicin
Malaysia
10,434
in 2021
Ukraine
9,237
in 2021
Malaysia rank
20th
Ukraine rank
23rd
The number of people with susceptibility test result for rifampicin over time
- Malaysia
- Ukraine
How they compare
Malaysia currently reports 10,434 against 9,237 in Ukraine, a difference of 1,197.
That makes Malaysia's figure about 1.1 times Ukraine's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Ukraine ahead.
Malaysia ranks 20th and Ukraine ranks 23rd of 155 countries.
Across the 2 decades both report, Malaysia averaged higher in 1 and Ukraine in 1.
Head to head by decade
| Decade | Malaysia | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 11,620 | 12,368 | 748 | Ukraine |
| 2020s | 10,381 | 9,015 | 1,366 | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malaysia or Ukraine?
- Malaysia, at 10,434 against 9,237 in Ukraine as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malaysia and Ukraine?
- 1,197, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Ukraine?
- 5 years are reported by both, from 2017 to 2021.
- How do Malaysia and Ukraine rank globally for the number of people with susceptibility test result for rifampicin?
- Malaysia ranks 20th and Ukraine ranks 23rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.